🇧🇷 Darzalex Faspro in Brazil

Darzalex Faspro (daratumumab-and-hyaluronidase-fihj) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Darzalex Faspro in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Darzalex Faspro approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Darzalex Faspro in Brazil?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.